Facebook pixel

VP – Product and Portfolio Strategy
Hematology
Confirmed live in the last 24 hours
Locations
Cambridge, MA, USA
Experience Level
Entry
Junior
Mid
Senior
Expert
Desired Skills
Communications
Requirements
  • BS/BA in a relevant academic field; MBA, MD, PhD, or other graduate degree strongly preferred
  • Extensive experience and track record with product strategy and commercial development with innovative medicines required
  • Genetic disease, gene therapy, and/or cell therapy experience strongly desired, particularly in autologous cell therapy
  • 10+ years' experience within the pharma/biotech/biopharma space in roles of progressively increasing responsibility
  • Proven track record in cross-functional leadership role or other cross-disciplinary background with successful team leadership experience required
  • Demonstrated ability to lead teams without direct reporting responsibility; exceptional interpersonal skills and collaborative nature with strong ability to influence, motivate, inspire, encourage and develop others
  • Driven by patient needs and comfortable operating in a highly scientific and technical environment while dealing with ambiguity
  • Strong collaboration, decision-making and conflict management skills with demonstrated proficiency
  • Excellent verbal and written communication skills including strong formal presentation skills and the ability to communicate complex scientific information in an understandable manner
  • Sophisticated understanding of the evolving scientific, clinical, regulatory, competitive, and economic trends impacting the industry, and able to adapt operational strategies accordingly
  • Experience in both large and small company environments a plus
Responsibilities
  • Build the product strategy for 101and 102 including life-cycle management and build pathway to commercialization
  • Create the roadmap to commercialization for an autologous cell therapy as Beam's first to launch asset (101), including manufacturing, slot allocation, messaging platform
  • Shape the portfolio strategy for the hematology portfolio including the ESCAPE platform (non-genotoxic conditioning platform) and in vivo delivery of SCD correction
  • Lead the hem portfolio prioritization, forecasting, and opportunity assessment as a leader of the Program Team Strategy Cross-functional Sub-team
  • Collaborate closely with the Program lead, Program Manager, and key functions (e.g., clinical) to shape timelines, development operations, publications
  • Build the external communications approach for Hematology (e.g., IR, science story)
  • Monitor competitive intelligence and define differentiation strategy for SCD
Beam Therapeutics

501-1,000 employees